Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 571-580 of 2859 for cancer

Edit search filters
  1. A First-in-Human (FIH) Study To Evaluate The Safety And Tolerability Of VVD-159642 In Participants With Advanced Solid Tumors

    Scottsdale/Phoenix, AZ

  2. Study To Evaluate The Long-term Safety Of Rusfertide (PTG-300) In Subjects With Polycythemia Vera

    Scottsdale/Phoenix, AZ

  3. A Study To Investigate The Safety And Efficacy Of KQB168 As Monotherapy And In Combination In Participants With Advanced Solid Malignancies

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  4. Pemigatinib To Treat Metastatic Or Unresectable Colorectal Cancer Harboring FGFR Alterations

    Scottsdale/Phoenix, AZ, Rochester, MN

  5. Randomized, Open Label, Clinical Study Of The Targeted Therapy, Palbociclib, To Treat Metastatic Breast Cancer

    Scottsdale/Phoenix, AZ, Rochester, MN

  6. A Study To Evaluate The Combination Of Margetuximab, Retifanlimab, MGD013, And Chemotherapy Phase 2/3 Trial In HER2+ Gastric/GEJ Cancer

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  7. A Study Of Adjuvant Cretostimogene Grenadenorepvec For Treatment Of Intermediate Risk NMIBC Following TURBT

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  8. Study Of Vorasidenib (AG-881) In Participants With Residual Or Recurrent Grade 2 Glioma With An IDH1 Or IDH2 Mutation (INDIGO)

    Jacksonville, FL, Rochester, MN

  9. A Study To Test The Addition Of Berzosertib To Usual Radiation Treatment For Chemotherapy-Resistant Breast Cancer

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  10. A Randomized Phase 2 Study Of Combination Atezolizumab And CDX-1127 (Varlilumab) With Or Without Addition Of Cobimetinib In Previously Treated Unresectable Biliary Tract Cancers

    Scottsdale/Phoenix, AZ, Rochester, MN

.

Mayo Clinic Footer